NAFLD in HIV Database (HIV & Non-Alcholic Fatty Liver Disease) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to better understand nonalcoholic fatty liver disease in people with HIV. We want to find out what are the most accurate, non-invasive diagnostic tests to detect scarring in the liver for people who have HIV. At this time, we do not have a good understanding of the following characteristics of steatotic liver disease in people with HIV:

Causes of the disease
Risk factors
The most accurate, non-invasive tests to measure liver scarring
How the disease progresses
Treatment options

What is the Condition Being Studied?

Human Immunodeficiency Virus (HIV) and Non-Alcoholic Fatty Liver Disease (NAFLD)

Who Can Participate in the Study?

Adults ages 18+ who:

Are diagnosed with HIV
Are diagnosed with steatotic liver disease or have a significant increase in liver stiffness
Have been on antiviral HIV treatment for at least 6 months and have not changed their dose of medicine for at least 3 months

For more information about who can join this study, contact the study team at 919-668-3199.

Age Group

Adults

What is Involved?

If you agree to join this study, you will:

Come in for a clinic visit at the start of the study, then visit us once a year for as long as you are enrolled in the study
Have a physical exam
Have a blood draw
Have a procedure done called Fibroscan (a painless, ultrasound-based test to check for liver fat or scarring)
Answer questionnaires

At your yearly follow-up visits, you will: